These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35021614)

  • 1. Donations Made and Received: A Study of Disclosure Practices of Pharmaceutical Companies and Patient Groups in Canada.
    Lexchin J
    Int J Health Policy Manag; 2022 Oct; 11(10):2046-2053. PubMed ID: 35021614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National patient groups in Canada and their disclosure of relationships with pharmaceutical companies: a cross-sectional study.
    Lexchin J; Batt S; Goldberg D; Shnier A
    BMJ Open; 2022 Mar; 12(3):e055287. PubMed ID: 35264357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Disclosure of Potential Conflicts of Interest in Dermatology Patient Advocacy Organizations.
    Li DG; Singer S; Mostaghimi A
    JAMA Dermatol; 2019 Apr; 155(4):460-464. PubMed ID: 30698625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Services and Policy Research in Canada: An Editor's Reflections.
    Lexchin J
    Healthc Policy; 2022 Feb; 17(3):42-48. PubMed ID: 35319443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient organizations' funding from pharmaceutical companies: is disclosure clear, complete and accessible to the public? An Italian survey.
    Colombo C; Mosconi P; Villani W; Garattini S
    PLoS One; 2012; 7(5):e34974. PubMed ID: 22590498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advertising and disclosure of funding on patient organisation websites: a cross-sectional survey.
    Ball DE; Tisocki K; Herxheimer A
    BMC Public Health; 2006 Aug; 6():201. PubMed ID: 16887025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transparency in relations between multinational R&D pharmaceutical companies' corporate social responsibility activities and patient organizations in the Europe, Japan, and the United States].
    Kato M; Ishikawa H; Okuhara T; Kiuchi T
    Nihon Koshu Eisei Zasshi; 2019; 66(12):746-755. PubMed ID: 31875625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Food Industry Donations to Academic Programs: A Cross-Sectional Examination of the Extent of Publicly Available Data.
    A Bragg M; Elbel B; Nestle M
    Int J Environ Res Public Health; 2020 Mar; 17(5):. PubMed ID: 32138233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicine donations: a review of policies and practices.
    Permaul Flores H; Kohler JC; Dimancesco D; Wong A; Lexchin J
    Global Health; 2023 Sep; 19(1):67. PubMed ID: 37658389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food industry donations to patient advocacy organisations focussed on non-communicable diseases.
    Del Giudice IM; Tsai KA; Arshonsky J; Bond S; Bragg MA
    Public Health Nutr; 2022 Oct; 26(3):1-9. PubMed ID: 36305342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment.
    Baronikova S; Purvis J; Southam E; Beeso J; Panayi A; Winchester C
    BMJ Evid Based Med; 2019 Oct; 24(5):177-184. PubMed ID: 30898790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and Distribution of Scholarship Donations From Pharmaceutical Companies to Japanese Healthcare Institutions in 2017: A Cross-sectional Analysis.
    Murayama A; Kamamoto S; Saito H; Yamashita E; Suzuki Y; Tanimoto T; Ozieranski P; Ozaki A
    Int J Health Policy Manag; 2023; 12():7621. PubMed ID: 38618821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
    D'Hooghe T
    Hum Reprod; 2017 Aug; 32(8):1549-1555. PubMed ID: 28854594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Clinical Anesthesiology, Mie University, and Ono Pharmaceutical in Japan.
    Ozaki A; Murayama A; Harada K; Saito H; Sawano T; Tanimoto T; Ozieranski P
    Front Public Health; 2021; 9():762637. PubMed ID: 35047471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is missing on their web sites? An evaluation of national and international pharmaceutical companies in Turkey.
    Yegenoglu S; Aslan D; Acar A; Calgan Z
    Telemed J E Health; 2005 Dec; 11(6):684-91. PubMed ID: 16430388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial conflicts of interest between pharmaceutical companies and executive board members of internal medicine subspecialty societies in Japan between 2016 and 2020.
    Murayama A; Saito H; Tanimoto T; Ozaki A
    J Eval Clin Pract; 2023 Sep; 29(6):883-886. PubMed ID: 37283452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview and transparency of non-research payments to healthcare organizations and healthcare professionals from pharmaceutical companies in Japan: Analysis of payment data in 2016.
    Ozaki A; Saito H; Senoo Y; Sawano T; Shimada Y; Kobashi Y; Yamamoto K; Suzuki Y; Tanimoto T
    Health Policy; 2020 Jul; 124(7):727-735. PubMed ID: 32439213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Payments reported by the pharmaceutical industry in Ireland from 2015 to 2019: An observational study.
    Moriarty F; Larkin J; Fahey T
    Health Policy; 2021 Oct; 125(10):1297-1304. PubMed ID: 34429238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Provision of information on regulatory authorities' websites.
    Vitry A; Lexchin J; Sasich L; Dupin-Spriet T; Reed T; Bertele V; Garattini S; Toop L; Hurley E
    Intern Med J; 2008 Jul; 38(7):559-67. PubMed ID: 18336542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.